Gainers
-
Retrophin Inc (NASDAQ: RTRX) rose 25.6 percent to
$20.49 in the pre-market trading session as the company disclosed that its Phase 2 DUET study of sparsentan achieved primary
efficacy endpoint.
-
Applied Optoelectronics Inc (NASDAQ: AAOI) shares
rose 20.5 percent to $20.98 in pre-market trading as the company lifted its Q3 forecast.
-
Francesca's Holdings Corp (NASDAQ: FRAN) rose
14.4 percent to $16.01 in pre-market trading after the company reported better-than-expected Q2 results and lifted its FY16
guidance.
-
Bioline RX Ltd (NASDAQ: BLRX) shares rose 13.2
percent to $1.020 in pre-market trading as the company announced a collaboration with Genentech to investigate combination of
BL-8040 with Atezolizumab.
-
Agios Pharmaceuticals Inc (NASDAQ: AGIO) shares
rose 11.7 percent to $41.70 in pre-market trading as the company disclosed that its partner Celgene Corporation (NASDAQ:
CELG) will submit a new drug application to the FDA for
enasidenib based on ongoing Phase 1/2 study.
-
Organovo Holdings Inc (NASDAQ: ONVO) shares rose
9.1 percent to $4.30 in pre-market trading after the company reported the initiation of commercial contracting for its ExVive
Human Kidney tissue.
-
Progenics Pharmaceuticals, Inc. (NASDAQ: PGNX)
rose 7.5 percent to $6.62 in pre-market trading. Valeant Pharmaceuticals Intl Inc and Progenics reported the U.S. commercial
launch of FDA-approved Relistor tablets.
-
Chipotle Mexican Grill, Inc. (NYSE: CMG) rose 5.8
percent to $438.00 in the pre-market trading after Bill Ackman’s Pershing Square disclosed a 9.9 percent stake in the company.
It should be noted that the 2,882,463 shares position has an activist nature, as suggested by the 13D SEC filing.
-
Western Digital Corp (NASDAQ: WDC) rose 5.1
percent to $49.95 in pre-market trading after the company increased its earnings and revenue forecast for the first quarter.
-
Ceragon Networks Ltd (NASDAQ: CRNT) rose 4
percent to $2.86 in pre-market trading after gaining 7.84 percent on Tuesday.
-
Valeant Pharmaceuticals Intl Inc (NYSE: VRX) rose
2.3 percent to $30.16 in pre-market trading following Relistor tablets launch news.
Find out what's going on in today's market and bring any questions you have to Benzinga's PreMarket Prep.
Losers
-
Sigma Designs Inc (NASDAQ: SIGM) shares fell 12.1
percent to $7.30 in the pre-market trading session. Sigma Designs reported stronger-than-expected quarterly earnings.
-
Sprouts Farmers Market Inc (NASDAQ: SFM) fell 11
percent to $20.30 in pre-market trading as the company lowered its full-year forecast and announced a $250 million buyback
plan.
-
HD Supply Holdings Inc (NASDAQ: HDS) shares fell
10.6 percent to $32.40 in pre-market trading as the company reported below than expected results for the second quarter.
-
Summit Midstream Partners LP (NYSE: SMLP) fell 7.9
percent to $22.90 in pre-market trading. Summit Midstream reported an offering of 5.5 million common shares.
-
Dave & Buster's Entertainment, Inc. (NASDAQ: PLAY) shares fell 6.9 percent to $43.10 in pre-market trading. Dave & Buster's
reported better-than-expected results for its second quarter, but issued a weak sales forecast.
-
Catalent Inc (NYSE: CTLT) shares fell 6.7 percent
to $23.60 in pre-market trading. Catalent announced a secondary offering of 19 million shares common stock.
-
Casey's General Stores Inc (NASDAQ: CASY) shares
fell 6.2 percent to $125.00 in pre-market trading after the company posted weak earnings for its first quarter on Tuesday.
-
Advanced Micro Devices, Inc. (NASDAQ: AMD) shares
fell 4 percent to $7.05 in pre-market trading. AMD reported a public offering of $600 million in common stock.
-
Whole Foods Market, Inc. (NASDAQ: WFM) shares fell
3.1 percent to $29.75 in pre-market trading after declining 0.26 percent on Tuesday.
-
Ollie's Bargain Outlet Holdings Inc (NASDAQ: OLLI) shares fell 2.1 percent to $26.65 in pre-market trading. Ollie's Bargain
Outlet reported a secondary offering of 13.725 million shares.
-
Callon Petroleum Company (NYSE: CPE) shares fell 2
percent to $15.00 in pre-market trading. Callon Petroleum priced its upsized 26 million share common stock offering for gross
proceeds of $379.6 million.
© 2016 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.